MedPath

The effect of Deoderag pan jell on external genital itching and burning in women with Candidiasis

Phase 3
Conditions
Candidiasis.
Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
N77.1*
Registration Number
IRCT2016080829255N1
Lead Sponsor
ictin drug industry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
168
Inclusion Criteria

Inclusion criteria of this study is marital statues, confirmed clinical diagnosis of candida vulvovaginitis, chief compliant of external symptoms and signs of vulvovaginitis, no usage of herbal medicine or any chemical antibiotics especially in the recent two weeks, no history of AUB, no usage of vaginal douching in the past 48 hours.
Exclusion criteria of this study are overt diabet melitus, Immunosuppressive diseases,Vaginal drugs usage (as creams or gels) during the 4 weeks prior to study pregnancy, menopause, cervicitis, positive history of candidiasis more than 3 times per recent year, abnormal pap smear per recent year,having more than one sexual partner, and PID.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical signs of candidia vaginitis. Timepoint: before and afert the intervention. Method of measurement: clinical pelvic exam observationform.;Clinical symptoms experienced by the patient. Timepoint: from the begining of the intervention untill finished it. Method of measurement: dailty patenit cheklist.
Secondary Outcome Measures
NameTimeMethod
Recurrence of the vaginitis. Timepoint: 4 weeks after the treatment. Method of measurement: recurrence evaluation form.;Level of drug use satisfaction. Timepoint: after the intervention. Method of measurement: drug use satisfaction form.
© Copyright 2025. All Rights Reserved by MedPath